Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 35 | 31 | −4 |
| Shares | 9.13M | 9.87M | +740.3K (+8.1%) |
| Value | $24.0M | $19.7M | −$4.27M (−17.8%) |
New holders (2)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 75,228 | $150.0K | 0.00% |
| Truvestments Capital LLC | 318 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 49,743 | $131.0K |
| Franklin Resources Inc | 43,700 | $115.0K |
| Dimensional Fund Advisors LP | 19,563 | $51.0K |
| UBS Group AG | 4,828 | $13.0K |
| Royal Bank of Canada | 4,000 | $11.0K |
| Morgan Stanley | 1,940 | $5.00K |